- EUKARYOTIC CELL, Feb. 2005, p. 465475 Vol. 4, No. 2 1535-9778/05/$08.00 0 doi:10.1128/EC.4.2.465475.2005
- Immunomodulators as an antimicrobial tool Liise-anne Pirofski1,2
- Available at www.sciencedirect.com journal homepage: http://intl.elsevierhealth.com/journals/tube
- Cryptococcus neoformans Capsular Glucuronoxylomannan Induces Expression of Fas Ligand in Macrophages1
- Irresponsible Journalism and Clinical Research CID 2006:43 (15 October) 1031 V I E W P O I N T S
- INFECTION AND IMMUNITY, Oct. 2005, p. 63506362 Vol. 73, No. 10 0019-9567/05/$08.00 0 doi:10.1128/IAI.73.10.63506362.2005
- CLINICAL AND VACCINE IMMUNOLOGY, Dec. 2007, p. 15501554 Vol. 14, No. 12 1556-6811/07/$08.00 0 doi:10.1128/CVI.00242-07
- CANCER BIOTHERAPY & RADIOPHARMACEUTICALS Volume 22, Number 3, 2007
- Binding of the wheat germ lectin to Cryptococcus neoformans suggests an association of chitin-like structures with yeast budding and capsular glucuronoxylomannan
- INFECTION AND IMMUNITY, Apr. 2005, p. 20122019 Vol. 73, No. 4 0019-9567/05/$08.00 0 doi:10.1128/IAI.73.4.20122019.2005
- INFECTION AND IMMUNITY, Mar. 2005, p. 17791787 Vol. 73, No. 3 0019-9567/05/$08.00 0 doi:10.1128/IAI.73.3.17791787.2005
- The capsular dynamics of Cryptococcus neoformans
- An Innate Immune System Cell Is a Major Determinant of Species-Related Susceptibility Differences to Fungal
- GXM-Induced Tolerance JID 2005:191 (1 January) 127 M A J O R A R T I C L E
- ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Jan. 2005, p. 350357 Vol. 49, No. 1 0066-4804/05/$08.00 0 doi:10.1128/AAC.49.1.350357.2005
- ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Mar. 2005, p. 952958 Vol. 49, No. 3 0066-4804/05/$08.00 0 doi:10.1128/AAC.49.3.952958.2005
- Radial mass density, charge, and epitope distribution in the1 Cryptococcus neoformans capsule2
- Current Biology 16, 21612165, November 7, 2006 2006 Elsevier Ltd All rights reserved DOI 10.1016/j.cub.2006.09.061 Phagosome Extrusion and Host-Cell
- 1178 JID 2006:193 (15 April) Goldman et al. M A J O R A R T I C L E
- Caspofungin reduces the incidence of fungal contamination in cell culture
- VORICONAZOLE INHIBITS MELANIZATION IN3 Cryptococcus neoformans4
- BRIEF REPORT JID 2006:194 (15 July) 261 B R I E F R E P O R T
- CLINICAL AND VACCINE IMMUNOLOGY, Feb. 2008, p. 392393 Vol. 15, No. 2 1556-6811/08/$08.00 0 doi:10.1128/CVI.00383-07
- Mouse Genetic Background Is a Major Determinant of Isotype-Related Differences for Antibody-Mediated Protective
- 1414 CID 2006:42 (15 May) EDITORIAL COMMENTARY E D I T O R I A L C O M M E N T A R Y
- ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Mar. 2006, p. 10211033 Vol. 50, No. 3 0066-4804/06/$08.00 0 doi:10.1128/AAC.50.3.10211033.2006
- A Reappraisal of Humoral Immunity Based on Mechanisms of AntibodyMediated Protection
- Phage Display Library Derived Peptides that Bind to Human Tumor Melanin as Potential Vehicles for Targeted Radionuclide Therapy of
- Cellular Microbiology (2006) 8(11), 17301739 doi:10.1111/j.1462-5822.2006.00742.x First published online 7 June 2006
- EUKARYOTIC CELL, Aug. 2007, p. 14641473 Vol. 6, No. 8 1535-9778/07/$08.00 0 doi:10.1128/EC.00162-07
- Fungal Genetics and Biology xxx (2006) xxxxxx www.elsevier.com/locate/yfgbi
